Carvedilol is associated with improved survival in patients with cirrhosis: a long‐term follow‐up study

Summary Background Primary prophylaxis of variceal haemorrhage with non‐selective beta blockers (NSBB) or variceal band ligation (VBL) is now standard of care in patients with cirrhosis with portal hypertension. NSBB, and particularly carvedilol, may be associated with improved survival. Aim To asse...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Alimentary pharmacology & therapeutics 2021-02, Vol.53 (4), p.531-539
Hauptverfasser:	McDowell, Hannah R., Chuah, Cher Shiong, Tripathi, Dhiraj, Stanley, Adrian J., Forrest, Ewan H., Hayes, Peter C.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adrenergic beta-Antagonists - therapeutic use Ascites Carvedilol - therapeutic use Cirrhosis Encephalopathy Esophageal and Gastric Varices - drug therapy Follow-Up Studies Gastrointestinal Hemorrhage - etiology Gastrointestinal Hemorrhage - prevention & control Hemorrhage Humans Hypertension Liver Liver cirrhosis Liver Cirrhosis - complications Liver Cirrhosis - drug therapy Liver transplantation Mortality Prophylaxis Prospective Studies Retrospective Studies Survival
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!